Table 5.
Short-term Effects of ECT on Cognitive Measures, According to Treatment Group.*
| Ultrabrief Right Unilateral ECT |
Ultrabrief Bilateral ECT |
Brief Pulse Right Unilateral ECT |
Brief Pulse Bilateral ECT |
PW | EP | EPxPW | No. of Treatments |
Age | Baseline Score |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Global Cognitive Status: Modified Mini-Mental State Exam | ||||||||||
| Post-Six ECT | +0.0±1.1a | −0.1±0.9a | −1.3±1.9b | −1.0±1.7b | 24.4¶ | 0.2 | 0.8 | — | 2.1 | 55.9¶ |
| Post-Treatment Course‖ | +0.2±1.0a | −0.2±1.0b | −0.6±1.2b | −0.6±1.1b | 13.2§ | 1.8 | 2.2 | 0.0 | 5.3† | 47.1¶ |
| Anterograde Memory: Delayed Reproduction Complex Figure Test | ||||||||||
| Post-Six ECT | −0.1±0.9a | −0.1±0.9a | −0.3±0.8a,b | −0.5±0.6b | 4.3† | 0.1 | 0.4 | — | 0.5 | 30.2¶ |
| Post-Treatment Course‖ | +0.2±1.0a | +0.1±0.8a | −0.3±0.9b | −0.4±0.7b | 11.4§ | 0.4 | 0.1 | 3.4 | 0.1 | 40.5¶ |
| Anterograde Memory: Delayed Recall Buschke Selective Reminding Test | ||||||||||
| Post-Six ECT | +0.4±1.1a | +0.3±0.9a | −0.4±1.0b | −0.3±0.7b | 18.3¶ | 0.2 | 0.4 | — | 1.9 | 37.2¶ |
| Post-Treatment Course‖ | +0.3±1.0a | +0.2±0.9a,b | −0.2±1.2b | −0.1±0.7b | 5.6† | 0.3 | 0.1 | 0.4 | 0.3 | 33.3¶ |
| Anterograde Memory: Randt Story Recall at 24 Hr Delay | ||||||||||
| Post-Six ECT | −0.2±0.9 | −0.3±1.2 | −0.9±0.7 | −0.7±1.1 | 4.5† | 0.3 | 0.3 | — | 0.7 | 11.4§ |
| Post-Treatment Course | +0.1±1.1a | −0.2±1.2a,b | −0.6±0.8a,b | −0.7±1.2b | 4.7† | 0.4 | 0.1 | 1.7 | 0.0 | 12.4§ |
| Retrograde Memory: Autobiographical Memory Interview | ||||||||||
| Post-Treatment Course‖ | 0.0±1.0a | −0.4±1.1b | −1.0±1.0c | −1.4±1.0d | 44.7¶ | 10.0‡ | 0.0 | 31.6¶ | 1.7 | 81.9¶ |
| Retrograde Memory: Goldberg Public Events | ||||||||||
| Post-Treatment Course‖ | 0.0±1.2a | −0.2±0.9a | −0.2±1.2a | −0.6±1.0b | 9.8‡ | 9.4‡ | 1.5 | 2.7 | 0.1 | 264.4¶ |
| Subjective Cognitive Evaluation | ||||||||||
| Global Memory Assessment‖ | −0.3±1.0a | −1.1±0.9b | −1.4±1.0b | −1.4±1.0b | 15.8§ | 7.5‡ | 0.7 | 8.6‡ | 10.0‡ | — |
Plus–minus values are means±SD. PW is the F-value for the main effect of pulse width from the ANCOVA. EP is F-value for the main effect of electrode placement. EPxPW is the F-value for the interaction between pulse width and electrode placement. No. of Treatments is the F-value for the covariate, number of ECT treatments. Age is the F-value for the covariate, patient age. For all measures lower values indicate greater impairment. Values with different letter superscripts differed significantly from each other in post hoc t-tests on least-squares adjusted means (P<0.05).
F-value was significant in the ANCOVA (P<0.05)
F-value was significant in the ANCOVA (P<0.01)
F-value was significant in the ANCOVA (P<0.001)
F-value was significant in the ANCOVA (P<0.0001).
Declared a priori as a primary outcome measure.